Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-249
Closed -$47.2K – 1229
2020
Q4
$47.2K Hold
249
– – ﹤0.01% 538
2020
Q3
$43.9K Hold
249
– – ﹤0.01% 483
2020
Q2
$38.2K Buy
249
+85
+52% +$12.9K ﹤0.01% 499
2020
Q1
$23K Sell
164
-59
-26% -$8.82K ﹤0.01% 530
2019
Q4
$34K Buy
223
+164
+278% +$24K ﹤0.01% 540
2019
Q3
$8.53K Hold
59
– – ﹤0.01% 820
2019
Q2
$8.78K Hold
59
– – ﹤0.01% 829
2019
Q1
$7.55K Buy
+59
New +$6.94K ﹤0.01% 873
2018
Q3
– Sell
-138
Closed -$14.5K – 1168
2018
Q2
$14.5K Buy
+138
New +$13.9K ﹤0.01% 757

Other funds holding STE

RBC Europe's STE Position: Q1 2021 in Review

RBC Europe sold out of Steris (STE) in Q1 2021, closing a stake of 249 shares — an estimated $47.2K sold.

RBC Europe first reported a position in STE in Q2 2018 and held it in 9 quarters. The position peaked at $47.2K in Q4 2020. 591 funds tracked by Wall St. Rank hold STE as of Q1 2021.

  • RBC Europe reported no remaining Steris position as of Q1 2021 after selling out during the quarter.
  • RBC Europe sold 249 Steris shares in Q1 2021, an estimated $47.2K.
  • RBC Europe first reported a position in Steris in Q2 2018 and held it in 9 quarters.
  • RBC Europe's Steris position peaked at $47.2K in Q4 2020.
  • 591 funds tracked by Wall St. Rank held Steris as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.